dechloroethylcyclophosphamide and Hodgkin Disease

dechloroethylcyclophosphamide has been researched along with Hodgkin Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Busse, D; Diehl, V; Engert, A; Fuhr, U; Hempel, G; Jaehde, U; Jetter, A; Josting, A; Kasel, D; Klimm, B; Merkel, U; Reif, S; Rietbrock, S; Schwab, M; Wilde, S	1

Trials

1 trial(s) available for dechloroethylcyclophosphamide and Hodgkin Disease

Article	Year
Population pharmacokinetics of the BEACOPP polychemotherapy regimen in Hodgkin's lymphoma and its effect on myelotoxicity. Clinical pharmacokinetics, 2007, Volume: 46, Issue:4 Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Body Surface Area; Cyclophosphamide; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Middle Aged; Phenotype; Platelet Count; Prednisone; Procarbazine; Vincristine	2007

Article

Year

Population pharmacokinetics of the BEACOPP polychemotherapy regimen in Hodgkin's lymphoma and its effect on myelotoxicity.

Clinical pharmacokinetics, 2007, Volume: 46, Issue:4

Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Body Surface Area; Cyclophosphamide; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Middle Aged; Phenotype; Platelet Count; Prednisone; Procarbazine; Vincristine

2007